MedPath

Nelfinavir

Generic Name
Nelfinavir
Brand Names
Viracept
Drug Type
Small Molecule
Chemical Formula
C32H45N3O4S
CAS Number
159989-64-7
Unique Ingredient Identifier
HO3OGH5D7I

Overview

Nelfinavir is a potent HIV-1 protease inhibitor. It is used in combination with other antiviral drugs in the treatment of HIV in both adults and children. Nelfinavir inhibits the HIV viral proteinase enzyme which prevents cleavage of the gag-pol polyprotein, resulting in noninfectious, immature viral particles.

Background

Nelfinavir is a potent HIV-1 protease inhibitor. It is used in combination with other antiviral drugs in the treatment of HIV in both adults and children. Nelfinavir inhibits the HIV viral proteinase enzyme which prevents cleavage of the gag-pol polyprotein, resulting in noninfectious, immature viral particles.

Indication

Used in combination with other antiviral drugs in the treatment of HIV in both adults and children.

Associated Conditions

  • Human Immunodeficiency Virus Type 1 (HIV-1) Infection

FDA Approved Products

VIRACEPT
Manufacturer:H.J. Harkins Company, Inc.
Route:ORAL
Strength:250 mg in 1 1
Approved: 2012/02/22
NDC:52959-289
VIRACEPT
Manufacturer:AGOURON
Route:ORAL
Strength:625 mg in 1 1
Approved: 2021/03/01
NDC:63010-027
VIRACEPT
Manufacturer:AGOURON
Route:ORAL
Strength:250 mg in 1 1
Approved: 2021/03/01
NDC:63010-010
Viracept
Manufacturer:State of Florida DOH Central Pharmacy
Route:ORAL
Strength:625 mg in 1 1
Approved: 2010/04/13
NDC:53808-0809

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath